# Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB in Femoropopliteal Arteries

> **NCT02717104** · — · COMPLETED · sponsor: **C. R. Bard** · enrollment: 249 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02717104
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-20
- **Primary completion:** 2018-03
- **Final completion:** 2020-06
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02717104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02717104, "Korean Post-market Registry Assessing the Clinical Use and Safety of the Lutonix DCB in Femoropopliteal Arteries". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02717104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*